Orchestra BioMed Holdings, Inc.
Orchestra BioMed Holdings, Inc. (OBIO) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · OBIO · as of Jun 9, 2026
Key Statistics
Explore Orchestra BioMed Holdings, Inc. Data
obio stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 5 · Buy rate: 80.0%
The OBIO analyst consensus is Buy, based on ratings from 5 Wall Street analysts over the past 3 months. The average 12-month price target is $13.00, representing +229.11% upside from the current price of $3.95.
Competitors & Peers
obio competitorsOBIO
AVTX
CRBU
ENTA
EPRX
IVAStock Performance
Full HistoryAbout Orchestra BioMed Holdings, Inc.
Orchestra BioMed Holdings, Inc. operates as an innovative company in the biomedical sector. Its leading product candidates are BackBeat Cardiac Neuromodulation Therapy (CNT), designed to manage hypert…
what is orchestra biomed holdings, inc. · obio stock overview · orchestra biomed holdings, inc. company profile · who is orchestra biomed holdings, inc. ceo · obio NASDAQ · orchestra biomed holdings, inc. headquarters · orchestra biomed holdings, inc. business segments
About Stock Overview & Key Data
Orchestra BioMed Holdings, Inc. (OBIO) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Aug 4, 2020. As of the latest trading session, OBIO stock price is $3.95, with a market capitalization of $236.5M. The stock has returned +18.26% over the past 12 months and -4.82% year-to-date.
According to 5 Wall Street analysts, the consensus rating for Orchestra BioMed Holdings, Inc. stock is Buy, with an average 12-month price target of $13.00. In fiscal year 2025, Orchestra BioMed Holdings, Inc. reported revenue of $33.5M and net income of -$52.7M. For detailed data — including Orchestra BioMed Holdings, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Orchestra BioMed Holdings, Inc. (OBIO) stock price is $3.95. The stock is traded on NASDAQ under the ticker symbol OBIO. The 52-week range is $2.20 – $5.42.